Yurong Lai

Also affiliated with Gilead Sciences (United Kingdom), Gilead Sciences (Spain), Gilead Sciences (United States), Gilead Sciences (Australia)

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans”.

The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108271

N/A

0DataRank · unranked

43 citations

Mengyue Yin, Aditya R. Kumar, Mayur K. Ladumor, Raymond Evers, Paresh P. Chothe +5 more

Editorial: Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022

Frontiers in Pharmacology(2022)10.3389/fphar.2022.1083163

N/A

0DataRank · unranked

1 citations

Massimo Valoti, Yurong Lai, Thomas P. C. Dorlo, Yan Li, Terry D. Hinds